Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,388,069
-$41,212 QoQ
Shares Held
8,857
-5.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#527
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BECKER CAPITAL MANAGEMENT INC holds $223,808,539 across 11 Drug Manufacturers - General names. NVS ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
246,132 | $62,510,144 | |
| 2 | MRK |
Merck & Co., Inc.
|
268,226 | $34,467,041 | |
| 3 | AZN |
Astrazeneca PLC
|
176,512 | $33,470,205 | |
| 4 | AMGN |
Amgen Inc
|
85,085 | $30,810,980 | |
| 5 | LLY |
ELI LILLY & Co
|
24,740 | $29,673,900 | |
| 6 | SNY |
Sanofi
|
346,469 | $14,780,367 | |
| 7 | PFE |
Pfizer Inc
|
469,672 | $11,309,701 | |
| 8 | ABBV |
AbbVie Inc.
|
15,542 | $3,910,988 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,388,069 | 8,857 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,429,281 | 9,357 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,301,630 | 9,441 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,215,330 | 9,477 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,146,811 | 9,477 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,056,495 | 9,477 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $922,206 | 9,477 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,092,920 | 9,502 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,049,802 | 9,861 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $953,854 | 9,861 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $981,024 | 9,716 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $993,746 | 9,756 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $984,477 | 9,756 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $902,152 | 9,806 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $891,414 | 9,826 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $749,458 | 9,860 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $838,537 | 9,920 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $870,480 | 9,920 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,066,521 | 12,193 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,020,450 | 12,478 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,140,682 | 12,502 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,078,501 | 12,617 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,152,518 | 12,205 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,061,346 | 12,205 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,095,680 | 12,545 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,034,335 | 12,545 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||